Keywords: A1m; peak ankle plantar flexion moment (terminal stance); A1a; peak ankle power absorption; A2a; peak ankle power generation; Abd; abduction; Add; adduction; Abs; absorption; deg; Degrees; Dorsi; dorsiflexion; Ext; extension; Flex; flexion; Gen; generatio
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: L; Dopa (levedopa); MAO; inhibitors (monoamine oxidase B); COMPT; inhibitors (catechol-o-methyl transferase); MPTP; (1-Methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine); MPPP; (1-Methyl-4-phenyl-4-propionoxypiperidine); MPDP; (1-Methyl-4-phenyl-1, 2-dihydrox
Keywords: ACC; Anterior Cingulate Cortex; BLA; Baso-Lateral Amygdala; DLS; Dorsolateral Striatum; DMS; Dorsomedial; IL; Infra-Limbic Cortex; lOFC; Lateral Orbitofrontal Cortex; MD; mediodorsal thalamus; mOFC; Medial Orbitofrontal Cortex; mPFC; medial prefrontal cor
Keywords: Adenosine receptor; Xanthine; A2A; Hypoxia; KW-6002; Synthesis;
Electrophysiological characterization of sleep/wake, activity and the response to caffeine in adult cynomolgus macaques
Keywords: A1; Adenosine sub-type 1 receptor; A2a; Adenosine sub-type 2 receptor; CAF; Caffeine; EEG; Electroencephalogram; EMG; Electromyogram; i.m.; Intramuscular; LMA; Locomotor activity; NHP; Non-human primate; NREM; Non-rapid eye movement; N1; NREM Stage 1; N2;
Inhibition of cytokine-mediated JNK signalling by purinergic P2Y11 receptors, a novel protective mechanism in endothelial cells
Keywords: G-protein coupled receptors; Interleukin-1β; C-Jun N-terminal kinase; Purinergic receptors; Inflammation; YM-254890 (PubChem CID: 9919454); H-89 (PubChem CID: 449241); NF340 (PubChem CID: 73755007); MRS2179 (PubChem CID: 24867852); ZM241385 (PubChem CID:
Method for rapid optimization of recombinant GPCR protein expression and stability using virus-like particles
Keywords: GPCR recombinant protein expression; Protein engineering; Virus-like particles; GPCR protein stabilization; Membrane protein; A2A; Adenosine A2A Receptor; eGFP; enhanced Green Fluorescent Protein; ESI; Electrospray Ionization; GALR3; Galanin Receptor Type
Cannabidiol: State of the art and new challenges for therapeutic applications
Keywords: (5-HT)1A; 5-hydroxytryptamine receptor; Â â9-THC; delta-9-tetrahydrocannabinol; 2-AG; 2-arachidonoylglycerol; A2A; adenosine receptor; AEA; anandamide; ALI; acute lung injury; Aml-1; acute myeloid leukemia; APP; amyloid precursor protein; AR; androgen r
Role of adenosine A2A receptor in cerebral ischemia reperfusion injury: Signaling to phosphorylated extracellular signal-regulated protein kinase (pERK1/2)
Keywords: BDNF; brain-derived neurotropic factor; cAMP; cyclic adenosine monophosphate; CGS21680; 3-[4-[2-[[6-amino-9-[(2R,3R,4S,5S)-5-(ethylcarbamoyl)-3,4-dihydroxy-oxolan-2-yl]purin-2-yl]amino]ethyl]phenyl]propanoic acid - selective adenosine A2A agonist; Cyt.
Mechanisms involved in the antinociception induced by spinal administration of inosine or guanine in mice
Keywords: A1; adenosine receptor type 1; A2A; adenosine receptor type 2A; A3; adenosine receptor type 3; ADP; adenosine diphosphate; AMP; adenosine monophosphate; AMPA; α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid; AOPCP; É,β-methyleneadenosine 5â²-diph
Expression of CD73 and A2A receptors in cells from subjects with obesity and type 2 diabetes mellitus
Keywords: A2A; receptor for adenosine 2A; T2D; type 2 diabetes mellitus; ZM241385; A2A antagonist; CGS21680; A2A agonist; BMI; body mass index; WHR; waist-hip ratio; FPG; fasting plasma glucose; HbA1c; hemoglobin A1c; LDL-c; low-density lipoprotein cholesterol; H
Mapping the binding pocket of a novel, high-affinity, slow dissociating tachykinin NK3 receptor antagonist: Biochemical and electrophysiological characterization
Keywords: RO5328673; Dual NK2/NK3 antagonist; Inositol phosphate accumulation; Firing frequency; Locomotor activity; NK3 modeling; SP; substance P; NKA; neurokinin A; NKB; neurokinin B; GPCRs; G-protein coupled receptors; IP; inositol phosphates; DA; dopamine; NA;
Opiate-induced changes in brain adenosine levels and narcotic drug responses
Keywords: Adk; adenosine kinase; A1; adenosine A1 receptor; A2a; adenosine A2a receptor; LC/MS; liquid chromatography with mass spectroscopy; LC/MS/MS; tandem mass spectroscopy; PBS; phosphate-buffered saline; opiates; metabolomic analysis;
Adenosine A2a receptor antagonists attenuate striatal adaptations following dopamine depletion
Keywords: Adenosine; Dopamine; A2a; D2; Cholinergic interneuron; Medium spiny neuron; Striatopallidal; Patch clamp; Two photon laser scanning microscopy; Spine; Parkinson's disease;
Potent and selective adenosine A2A receptor antagonists: [1,2,4]-triazolo[4,3-c]pyrimidin-3-ones
Keywords: Adenosine; A2A; A2A receptor; A2A antagonist; Adenosine receptor; Parkinson’s disease
A2A receptor knockout worsens survival and motor behaviour in a transgenic mouse model of Huntington's disease
Keywords: Adenosine receptor; A2A; Huntington's disease; N171-82Q; Transgenic model; Striatum
It's all B2B…and beyond: Toward a systems perspective of the market
Keywords: Service-dominant logic; Service systems; Co-creation; B2B; A2A
Identification of anti-inflammatory targets for Huntington's disease using a brain slice-based screening assay
Keywords: Adenosine; A2A; JNK; IKK; CXCR3; Microglia; Neurodegeneration; Neuroprotection; Biolistics; Brain slice; Drug discovery; Inflammation;
The emergence of designed multiple ligands for neurodegenerative disorders
Keywords: ACh; acetylcholine; A2A; adenosine receptor subtype two-A; Aβ; amyloid-beta; ACE; angiotensin converting enzyme; BDNF; brain derived neurotrophic factor; GDNF; glial derived neurotrophic factors; MAO-B; monoamine oxidase B; AChE; acetylcholinesterase; AP
Synthetic studies on selective adenosine A2A receptor antagonists. Part II: Synthesis and structure-activity relationships of novel benzofuran derivatives
Keywords: Adenosine; A2A; A2A Receptor; A2A Antagonist; A2A Receptor antagonist; Parkinson's disease;
Hit-to-lead optimization of a series of carboxamides of ethyl 2-amino-4-phenylthiazole-5-carboxylates as novel adenosine A2A receptor antagonists
Keywords: A2A; Adenosine; Antagonist; Parkinson’s Disease
Synthetic studies on selective adenosine A2A receptor antagonists: Synthesis and structure–activity relationships of novel benzofuran derivatives
Keywords: Adenosine; A2A; A2A receptor; A2A antagonist; A2A receptor antagonist; Parkinson’s disease
Preladenant, a selective A2A receptor antagonist, is active in primate models of movement disorders
Keywords: Preladenant; MPTP; Extrapyramidal Syndrome; Monkey; Parkinson's Disease; A2A; Adenosine; Movement disorder
Adenosine antagonists reverse the cataleptic effects of haloperidol: Implications for the treatment of Parkinson's disease
Keywords: Dopamine; Adenosine; Parkinson's disease; Rat; Caffeine; CPT; SCH23390; A1; A2A; Basal ganglia
Modification upon aging of the density of presynaptic modulation systems in the hippocampus
Keywords: Aging; Nerve terminals; Density; Adenosine; A1; A2A; CB1; P2Y1; Metabotropic; Glutamate; MGluR5; GABA; Acetylcholine; Synaptophysin
Biaryl and heteroaryl derivatives of SCH 58261 as potent and selective adenosine A2A receptor antagonists
Keywords: Adenosine; A2A; A2A receptor; A2A antagonist; A2A receptor antagonist; SCH 58261; Parkinson’s Disease
Design, synthesis, and evaluation of fused heterocyclic analogs of SCH 58261 as adenosine A2A receptor antagonists
Keywords: Adenosine; A2A; A2A receptor; A2A antagonist; A2A receptor antagonist; SCH 58261; Parkinson’s Disease
A1 and A2A receptor activation by endogenous adenosine is required for VIP enhancement of K+-evoked [3H]-GABA release from rat hippocampal nerve terminals
Keywords: Adenosine; A1; A2A; VIP; GABA release; Synaptosomes
Antagonistic cannabinoid CB1/dopamine D2 receptor interactions in striatal CB1/D2 heteromers. A combined neurochemical and behavioral analysis
Keywords: CB1; D2; A2A; Receptor–receptor interactions; Striatum; FRETAC, adenylyl cyclase; DARPP-32, dopamine- and cAMP-regulated phosphoprotein of 32 kDa; FRET, fluorescence resonance energy transfer; GFP2, green fluorescent protein; MSN, medium spiny neuron; PKA
The role of adenosine A2 receptors in the regulation of TNF-α production and PGE2 release in mouse peritoneal macrophages
Keywords: Adenosine receptors; A2A; Macrophages; TNF-α; Prostaglandin E2
Identification of non-furan containing A2A antagonists using database mining and molecular similarity approaches
Keywords: A2A; Database mining; Molecular similarity; Non-furan; Pharmacophore
Adenosine receptor modelling. A1/A2a selectivity
Keywords: Adenosine receptor; A1; A2a; Docking; Receptor modelling
The role of adenosine A2A and A2B receptors in the regulation of TNF-α production by human monocytes
Keywords: 2-Cl-IB-MECA; 1-[2-chloro-6-[[(3-iodophenyl)methyl]amino]-9H-purin-9-yl]-1-deoxy-N-methyl-b-d-ribofuranuronamide; CCPA; 2-chloro-N6-cyclopentyladenosine; CGS21680; 4-[2-[[6-Amino-9-(N-ethyl-b-d-ribofuranuronamidosyl)-9H-purin-2-yl]amino]ethyl]benzenepropa